PubMed

Decisional attributes of patients with diabetes: the aspirin choice.

Montori VM, Bryant SC, O'Connor AM, Jorgensen NW, Walsh EE, Smith SA.

Diabetes Care. 2003 Oct;26(10):2804-9.PMID: 14514583 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group.

Diabetes Care. 2003 Dec;26(12):3264-72.PMID: 14633812 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain.

Sicras-Mainar A, Navarro-Artieda R, Rejas-Gutiérrez J, Fernández-de-Bobadilla J, Frías-Garrido X, Ruiz-Riera R.

BMC Fam Pract. 2007 Oct 17;8:60.PMID: 17941978 [PubMed - indexed for MEDLINE]Related articlesFree article

Age threshold for vascular prophylaxis by aspirin in patients without diabetes.

Bulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando DJ, Idris I.

Heart. 2008 Nov;94(11):1429-32. Epub 2008 Aug 15.PMID: 18708419 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.PMID: 15955469 [PubMed - indexed for MEDLINE]Related articles

Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.

Bruno A, Grassi G, Dani F, Degiovanni M, Maghenzani G, Pagano G.

Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):42-6.PMID: 15871850 [PubMed - indexed for MEDLINE]Related articles

Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.

Bulatova NR, Yousef AM, AbuRuz SM.

Thromb Res. 2007;121(1):43-50. Epub 2007 Apr 25.PMID: 17462716 [PubMed - indexed for MEDLINE]Related articles

[Factors that influence the implementation of the guidelines for aspirin use by diabetic patients in Israel]

Azuz N, Thomas K, Yaffe Y, Katz M, Weingarten M, Matalon A.

Harefuah. 2008 Dec;147(12):971-4, 1030. Hebrew. PMID: 19260592 [PubMed - indexed for MEDLINE]Related articles

Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Feher G, Koltai K, Papp E, Alkonyi B, Solyom A, Kenyeres P, Kesmarky G, Czopf L, Toth K.

Drugs Aging. 2006;23(7):559-67.PMID: 16930084 [PubMed - indexed for MEDLINE]Related articles

[Aspirin use in patients with diabetes mellitus]

Sicras Mainar A, Ruiz Riera R, Frías Garrido X, Navarro Artieda R.

Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239. Spanish. No abstract available. PMID: 15282081 [PubMed - indexed for MEDLINE]Related articles

The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management.

Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S.

Diabetes Care. 2005 Apr;28(4):816-22.PMID: 15793179 [PubMed - indexed for MEDLINE]Related articlesFree article

[Should we treat all diabetic patients with aspirin in primary prevention?]

Righetti A, De Moerloose P, Philippe J.

Rev Med Suisse. 2005 Jun 1;1(22):1500-4. Review. French. PMID: 16025889 [PubMed - indexed for MEDLINE]Related articles

Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada.

Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR.

Clin Ther. 2004 Mar;26(3):439-46.PMID: 15110137 [PubMed - indexed for MEDLINE]Related articles

Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

Morimoto T, Fukui T, Lee TH, Matsui K.

Am J Med. 2004 Oct 1;117(7):459-68. Review.PMID: 15464702 [PubMed - indexed for MEDLINE]Related articles

Antiplatelet therapy for primary prevention in diabetes.

Ambrosi P, Villani P, Bouvenot G.

Diabetes Metab. 2006 Sep;32 Spec No2:2S52-6. Review.PMID: 17375409 [PubMed - indexed for MEDLINE]Related articles

Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.

Hennekens CH, Knatterud GL, Pfeffer MA.

Diabetes Care. 2004 Nov;27(11):2752-4. Review. No abstract available. PMID: 15505018 [PubMed - indexed for MEDLINE]Related articlesFree article

Improving aspirin prophylaxis in a primary care diabetic population.

Faragon JJ, Waite NM, Hobson EH, Seoldo N, VanAmburgh JA, Migden H.

Pharmacotherapy. 2003 Jan;23(1):73-9.PMID: 12523462 [PubMed - indexed for MEDLINE]Related articles

Aspirin use and counseling about aspirin among patients with diabetes.

Krein SL, Vijan S, Pogach LM, Hogan MM, Kerr EA.

Diabetes Care. 2002 Jun;25(6):965-70.PMID: 12032100 [PubMed - indexed for MEDLINE]Related articlesFree article

[Use of aspirin in diabetic patients]

Türkoğlu S, Abaci A.

Anadolu Kardiyol Derg. 2007 Dec;7 Suppl 2:5-8. Review. Turkish. PMID: 18160360 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin for primary prevention of cardiovascular events.

Augustovski FA, Cantor SB, Thach CT, Spann SJ.

J Gen Intern Med. 1998 Dec;13(12):824-35.PMID: 9844080 [PubMed - indexed for MEDLINE]Related articlesFree article